Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Its structure enables strong binding to enzyme active sites, enhancing drug efficacy. Also employed in agrochemicals to improve the stability and activity of crop protection compounds. The trifluoromethyl group contributes to increased metabolic stability and lipophilicity, making it valuable in optimizing pharmacokinetic properties in drug design.